Following our previous post on extended 4°C holding, we also looked at what happens after thawing. In many MSC workflows, cells do not move directly from thawing to the next step. They may need to w...
In CAR-NK cryopreservation, viability alone is not enough. Functional retention after thaw is what really matters. We recently reviewed a CAR-NK cryopreservation validation case with CS-AT-D2, our cr...
Cryopreservation is not unique to iMSC — it is a shared challenge across almost all cell therapy workflows.But for off-the-shelf iMSC development, this step becomes especially important. Why? Because...
In Cell & Gene Therapy (CGT), long-term T cell stability directly affects process robustness, batch consistency, and downstream efficacy.CS-DX-N2, a DMSO-free cryopreservation medium from CellStor...
7 days in the freezer? Most media drop MSC viability—but CS-DX-N2 keeps >90% of cells alive, with markers virtually unchanged from fresh.For cell therapy and regenerative medicine researchers, DMS...
